Correlation Between MERCK Kommanditgesells and Isracann Biosciences

Can any of the company-specific risk be diversified away by investing in both MERCK Kommanditgesells and Isracann Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MERCK Kommanditgesells and Isracann Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MERCK Kommanditgesellschaft auf and Isracann Biosciences, you can compare the effects of market volatilities on MERCK Kommanditgesells and Isracann Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MERCK Kommanditgesells with a short position of Isracann Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of MERCK Kommanditgesells and Isracann Biosciences.

Diversification Opportunities for MERCK Kommanditgesells and Isracann Biosciences

0.0

Correlation Coefficient

MERCK Kommanditgesells  Isracann Biosciences

Pay attention - limited upside

The 3 months correlation between MERCK and Isracann is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding MERCK Kommanditgesellschaft au and Isracann Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Isracann Biosciences and MERCK Kommanditgesells is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MERCK Kommanditgesellschaft auf are associated (or correlated) with Isracann Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Isracann Biosciences has no effect on the direction of MERCK Kommanditgesells i.e., MERCK Kommanditgesells and Isracann Biosciences go up and down completely randomly.

Pair Corralation between MERCK Kommanditgesells and Isracann Biosciences

If you would invest  14,625  in MERCK Kommanditgesellschaft auf on December 2, 2024 and sell it today you would lose (100.00) from holding MERCK Kommanditgesellschaft auf or give up 0.68% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	97.5%
Values	Daily Returns

MERCK Kommanditgesellschaft au  vs.  Isracann Biosciences

MERCK Kommanditgesells

Risk-Adjusted Performance

Very Weak

Over the last 90 days MERCK Kommanditgesellschaft auf has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, MERCK Kommanditgesells is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Isracann Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Isracann Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Isracann Biosciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with MERCK Kommanditgesells and Isracann Biosciences

The main advantage of trading using opposite MERCK Kommanditgesells and Isracann Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MERCK Kommanditgesells position performs unexpectedly, Isracann Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Isracann Biosciences will offset losses from the drop in Isracann Biosciences' long position.

The idea behind MERCK Kommanditgesellschaft auf and Isracann Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.